Atlas Trials

Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

Clinical trial NCT00289536 · COMPLETED

Trial details

NCT number
NCT00289536
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hemophilia A
Start date
2006-02-02
Primary completion
2007-04-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.